I-123 MIBG Cardiac Imaging

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2015 Apr 1

PMID 25824015

Citations 12

Authors

Prem Soman

Mark I Travin

Myron Gerson

S James Cullom

Randall Thompson

Affiliations

Soon will be listed here.

Citing Articles

Diagnostic Efficacy of Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies.

Hagen J, Scheifele M, Zacherl M, Katzdobler S, Bernhardt A, Brendel M Diagnostics (Basel). 2025; 15(1.

PMID: 39795552 PMC: 11720076. DOI: 10.3390/diagnostics15010024.

Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.

Chang M, Peng C, Chen C, Shih Y, Chen J, Tai Y Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770405 PMC: 11676292. DOI: 10.3390/ph17121563.

Three-Dimensional Heart Segmentation and Absolute Quantitation of Cardiac I-metaiodobenzylguanidine Sympathetic Imaging Using SPECT/CT.

Saito S, Nakajima K, Shibutani T, Wakabayashi H, Yoneyama H, Konishi T Ann Nucl Cardiol. 2023; 9(1):61-67.

PMID: 38058582 PMC: 10696146. DOI: 10.17996/anc.23-00002.

Optimal Protocol and Clinical Usefulness of I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson's Disease and Dementia with Lewy Body from Non-Parkinson's Diseases.

Chun I Nucl Med Mol Imaging. 2023; 57(3):145-154.

PMID: 37187951 PMC: 10172433. DOI: 10.1007/s13139-023-00790-w.

Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation-A Prospective I-mIBG-SPECT/CT Imaging Study.

Lange P, Wenning C, Avramovic N, Leitz P, Larbig R, Frommeyer G J Pers Med. 2021; 11(10).

PMID: 34683135 PMC: 8549007. DOI: 10.3390/jpm11100995.

References

Murata K, Kusachi S, Murakami T, Nogami K, Murakami M, Hirohata S . Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy. Clin Cardiol. 1997; 20(1):61-6. PMC: 6656273. DOI: 10.1002/clc.4960200113. View

Travin M . Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol. 2012; 20(1):128-43. DOI: 10.1007/s12350-012-9655-1. View

Gerson M, Craft L, McGuire N, Suresh D, Abraham W, Wagoner L . Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine. J Nucl Cardiol. 2002; 9(6):608-15. DOI: 10.1067/mnc.2002.127717. View

Gerson M, Dwivedi A, Abdallah M, Shukla R, Jacobson A . Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects. J Nucl Cardiol. 2013; 20(4):592-9. DOI: 10.1007/s12350-013-9714-2. View

Bax J, Kraft O, Buxton A, Fjeld J, Parizek P, Agostini D . 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2009; 1(2):131-40. DOI: 10.1161/CIRCIMAGING.108.782433. View

Jain D, Thompson B, Wackers F, Zaret B . Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study. J Am Coll Cardiol. 1997; 30(2):421-9. DOI: 10.1016/s0735-1097(97)00164-2. View

Bohm M, La Rosee K, Schwinger R, Erdmann E . Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol. 1995; 25(1):146-53. DOI: 10.1016/0735-1097(94)00353-r. View

Bombardieri E, Giammarile F, Aktolun C, Baum R, Bischof Delaloye A, Maffioli L . 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2010; 37(12):2436-46. DOI: 10.1007/s00259-010-1545-7. View

Somsen G, Verberne H, Fleury E, Righetti A . Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol. 2004; 11(2):126-33. DOI: 10.1016/j.nuclcard.2003.10.010. View

10.

Jacobson A, Senior R, Cerqueira M, Wong N, Thomas G, Lopez V . Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010; 55(20):2212-21. DOI: 10.1016/j.jacc.2010.01.014. View

11.

Agostini D, Belin A, Amar M, Darlas Y, Hamon M, Grollier G . Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med. 2000; 41(5):845-51. View

12.

Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M . Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010; 37(9):1802-12. DOI: 10.1007/s00259-010-1491-4. View

13.

Yamada T, Shimonagata T, Fukunami M, Kumagai K, Ogita H, Hirata A . Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol. 2003; 41(2):231-8. DOI: 10.1016/s0735-1097(02)02700-6. View

14.

Leslie W, Tully S, Yogendran M, Ward L, Nour K, Metge C . Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2005; 45(10):1676-82. DOI: 10.1016/j.jacc.2005.02.059. View

15.

Ketchum E, Jacobson A, Caldwell J, Senior R, Cerqueira M, Thomas G . Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol. 2012; 19(5):1007-16. DOI: 10.1007/s12350-012-9603-0. View

16.

Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin M . Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med. 2001; 42(12):1757-67. View

17.

Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S . Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 1997; 38(1):49-52. View

18.

Giammarile F, Chiti A, Lassmann M, Brans B, Flux G . EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008; 35(5):1039-47. DOI: 10.1007/s00259-008-0715-3. View